SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-087025
Filing Date
2023-08-03
Accepted
2023-08-03 07:06:01
Documents
14
Period of Report
2023-08-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2322717d1_8k.htm   iXBRL 8-K 29856
2 EXHIBIT 99.1 tm2322717d1_ex99-1.htm EX-99.1 11272
6 GRAPHIC tm2322717d1_ex99-1img001.jpg GRAPHIC 4444
  Complete submission text file 0001104659-23-087025.txt   228639

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cara-20230802.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20230802_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20230802_pre.xml EX-101.PRE 22375
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2322717d1_8k_htm.xml XML 3423
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 231138020
SIC: 2834 Pharmaceutical Preparations